Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PFMT with Biofeedback and Medication in Women With Overactive Bladder
NCT04477265Completed
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Jun 2016
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of solifenacin in overactive bladder (OAB) (3 arms), sponsored by Far Eastern Memorial Hospital. Primary endpoints: 3-Day Voiding Diary at 12 weeks, Symptom Distress Scale at 12 weeks and 4 more. Started Jun 2016; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT04477265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04477265.